Expert Review of Gastroenterology & Hepatology

Papers
(The H4-Index of Expert Review of Gastroenterology & Hepatology is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
COVID-19 and hygiene hypothesis: increment of the inflammatory bowel diseases in next generation?207
Managing pain in irritable bowel syndrome: current perspectives and best practice75
Ripretinib for the treatment of adult patients with advanced gastrointestinal stromal tumors35
Imaging in pediatric disorders of the gut-brain interactions: current best practice and future directions34
Small bowel transplant – novel indications and recent progress34
Prevention of pancreatitis after stent implantation for distal malignant biliary strictures: systematic review and meta-analysis28
Elucidating the role of extracellular vesicles in liver injury induced by HIV25
Virologic response maintenance and hepatocellular carcinoma in chronic hepatitis B patients treated with entecavir25
Therapeutic drug monitoring in inflammatory bowel disease: recent developments23
Lipid biomarkers in colorectal cancer, with particular emphasis on exosomes – current status and future inferences22
Targeting liver metabolism: a pathway to cure hepatitis B virus?21
Terlipressin in the management of adults with hepatorenal syndrome-acute kidney injury (HRS-AKI)21
Irritable bowel syndrome – controversies in diagnosis and management20
Recent advances in treating constipation in children20
The assessment of impaired liver function and prognosis in hepatocellular carcinoma20
A narrative review on the diagnosis and management of constipation in infants19
Gender-related differences in celiac disease presentation and follow-up in adult patients19
Familial intestinal polyposis and device assisted enteroscopy: where do we stand?19
ERCP-related adverse events: incidence, mechanisms, risk factors, prevention, and management18
Early alpha-fetoprotein response predicts prognosis of immune checkpoint inhibitor and targeted therapy for hepatocellular carcinoma: a systematic review with meta-analysis18
Bayesian analysis and the role of local palliative therapeutics for malignant biliary obstruction18
0.092383146286011